PHC.V - Pathway Health Corp.
| Previous Close | 0.0550 |
| Open | 0.0550 |
| Bid | 0.0500 x N/A |
| Ask | 0.0550 x N/A |
| Day's Range | 0.0550 - 0.0550 |
| 52 Week Range | 0.0300 - 0.1000 |
| Volume | |
| Avg. Volume | 17,658 |
| Market Cap | 5.155M |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0900 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
NewsfileThe Newly Institute Announces Growth Updates on Canada-Wide Clinic Expansion, Key Programs and Patient Access
National clinic expansion, the addition of corporate mental health programs and improved patient access are helping define The Newly as a national leader in mental health and wellness Highlights:Strength of the Newly's protocols is helping establish the Company as a key partner for Worker's Compensation Boards across CanadaNew clinics in British Columbia and Nova Scotia anticipated to open in 2023Expected launch of the first Center of Excellence in Toronto, Ontario in 2024Expanding service offer
CNW GroupPATHWAY HEALTH, THE NEWLY INSTITUTE AND HEAL GLOBAL HOLDINGS ANNOUNCE FURTHER UPDATES IN ANTICIPATION OF COMPLETION OF PROPOSED TRANSACTION
Pathway Health Corp. (TSXV: PHC) (Frankfurt: KL1) ("Pathway" or the "Company"), The Newly Institute Inc. ("Newly") and HEAL Global Holdings Corp. ("HEAL Global"), are pleased to announce further updates to the anticipated business acquisition, recapitalization and debt restructuring transaction pursuant to the previously announced arrangement (see press releases dated December 22, 2022, March 1, 2023, March 31, 2023 and April 27, 2023) (the "Proposed Transaction") by way of plan of arrangement p
NewsfileThe Newly Institute, Pathway Health, and HEAL Global Holdings Announce Business, Strategy and Financing Updates in Anticipation of Completion of Proposed Transaction
HighlightsThe Newly Institute, Pathway Health, and HEAL Global Holdings combination to create a leading integrated mental health, chronic pain management, and wellness foundation for growthSynergistically designed to address growing $700 billion[1] global market opportunity for mental health, chronic pain and wellness Strategic growth plan in place to expand service offerings, cross-sell, and expand clinical footprint across the countryPathway secured additional $1 million secured debt funding f
CNW GroupPATHWAY HEALTH, THE NEWLY INSTITUTE, AND HEAL GLOBAL HOLDINGS ANNOUNCE BUSINESS, STRATEGY AND FINANCING UPDATES IN ANTICIPATION OF COMPLETION OF PROPOSED TRANSACTION
Pathway Health Corp. (TSXV: PHC) (Frankfurt: KL1) ("Pathway"), The Newly Institute Inc. ("Newly") and HEAL Global Holdings Corp. ("HEAL Global"), are pleased to announce updates to the anticipated combined business and strategy, including the strategy for the Canadian business (anticipated to operate as "HEAL Canada"), key growth initiatives and financings as well as introduction of the future CEO of the combined company post closing of the previously announced proposed business acquisition, rec
CNW GroupPathway Health Corp. announces the Shareholder Meeting and Receipt of Interim Court Order for Proposed Arrangement
Pathway Health Corp. (TSXV: PHC) (Frankfurt: KL1) ("Pathway" or the "Company"), a Canadian leader in chronic pain solutions and management services, is pleased to announce the joint information circular and proxy statement (the "Circular") and related materials will be mailed on or about May 1, 2023 for the annual and special meeting (the "Meeting") of the Company's common shareholders, (the "Shareholders") to vote, among other things, on the previously announced arrangement (see press releases
CNW GroupPATHWAY ANNOUNCES SHORT TERM BRIDGE LOAN
Pathway Health Corp. (TSXV: PHC) (Frankfurt: KL1) ("Pathway" or the "Company") is pleased to announce that Avonlea-Drewry Holdings Inc. ("ADH"), the Company's largest indirect shareholder and secured creditor, has made a secured loan of $1.0 million to the Company pursuant to a secured promissory grid note (the "Loan"). The proceeds of the Loan will assist Pathway with working capital obligations and ongoing transaction expenses prior to closing of the previously announced proposed business acqu
CNW GroupPathway Health Corp. Reports Fourth Quarter 2022 Financial Results
Pathway Health Corp. (TSXV: PHC) (Frankfurt: KL1) ("Pathway" or the "Company"), a Canadian leader in chronic pain solutions and management services, is pleased to report its financial results for the three and twelve-month period ended December 31, 2022. Unless otherwise noted, all amounts are in Canadian dollars and are prepared in accordance with International Financial Reporting Standards ("IFRS").
NewsfileThe Newly Institute, Heal Global Holdings, and Pathway Health Enter into Definitive Agreement in Connection with Recapitalization and Debt Restructuring
Toronto, Ontario--(Newsfile Corp. - April 1, 2023) - The Newly Institute Inc. (“The Newly”), HEAL Global Holdings Corp. (“HEAL”), and Pathway Health Corp. (TSXV: PHC) (FSE: KL1) (“Pathway” or the “Corporation”), an integrated healthcare company that provides products and services to patients suffering from chronic pain and related conditions, today announced, further to its news releases dated December 22, 2022 and March 1, 2023, that the Corporation has entered into a definitive arrangement agr
CNW GroupPATHWAY HEALTH CORP. ENTERS INTO DEFINITIVE AGREEMENT IN CONNECTION WITH RECAPITALIZATION AND DEBT RESTRUCTURING
Pathway Health Corp. (TSXV: PHC) (Frankfurt: KL1) ("Pathway" or the "Corporation"), an integrated healthcare company that provides products and services to patients suffering from chronic pain and related conditions, today announced, further to its news releases dated December 22, 2022 and March 1, 2023, that the Corporation has entered into a definitive arrangement agreement (the "Arrangement Agreement") dated March 31, 2023 with The Newly Institute Inc. ("The Newly"), a premier operator of int
CNW GroupPATHWAY ANNOUNCES FINAL DRAW-DOWN UNDER BRIDGE LOAN
Pathway Health Corp. (TSXV: PHC) ("Pathway" or the "Company") is pleased to announce that, further to its press releases of February 3, 2023, February 9, 2023 and February 17, 2023, it has made its third and final draw in the amount of $250,000 (the "Draw Down") under the $1.25 million secured convertible promissory grid note (the "Note") with HEAL Global Holdings Corp. (the "Lender"), an entity controlled by the Company's largest indirect beneficial shareholder Avonlea-Drewry Holdings Inc., and
CNW GroupPATHWAY HEALTH CORP. PROVIDES UPDATE ON PROPOSED BUSINESS ACQUISITION, RECAPITALIZATION AND DEBT RESTRUCTURING
Pathway Health Corp. (TSXV: PHC) (Frankfurt: KL1) ("Pathway" or the "Corporation") is pleased to provide an update on its proposed acquisition of all the issued and outstanding common shares of each of HEAL Global Holdings Corp. ("HEAL") and The Newly Institute Inc. ("The Newly") from their respective shareholders in exchange for common shares in the capital of Pathway to be completed by way of an arrangement ("Proposed Transaction") pursuant to a plan of arrangement under the Business Corporati
- Baystreet
Stocks in play: Pathway Health Corp.
Has made its second draw down in the amount of $500,000 under the $1.25-million secured convertible ...
CNW GroupPATHWAY ANNOUNCES SECOND DRAW-DOWN UNDER BRIDGE LOAN
Pathway Health Corp. (TSXV: PHC) (Frankfurt: KL1) ("Pathway" or the "Company") is pleased to announce that, further to its press releases of February 3, 2023 and February 9, 2023, it has made its second draw down in the amount of $500,000 (the "Draw Down") under the $1.25 million secured convertible promissory grid note (the "Note") with HEAL Global Holdings Corp. (the "Lender"), an entity controlled by the Company's largest indirect beneficial shareholder Avonlea-Drewry Holdings Inc., and which
CNW GroupPATHWAY ANNOUNCES FIRST DRAW-DOWN UNDER BRIDGE LOAN
Pathway Health Corp. (TSXV: PHC) ("Pathway" or the "Company") is pleased to announce that, further to its press release of February 3, 2023, it has elected to draw down $500,000 (the "Draw Down") under the $1.25 million secured convertible promissory grid note (the "Note") with HEAL Global Holdings Corp. (the "Lender"), an entity controlled by the Company's largest indirect beneficial shareholder Avonlea-Drewry Holdings Inc., and which is a party to the Company's previously announced letter of i
CNW GroupPATHWAY ANNOUNCES BRIDGE LOAN
Pathway Health Corp. (TSXV: PHC) ("Pathway" or the "Company") is pleased to announce a proposed $1.25 million private placement of a secured convertible promissory note with HEAL Global Holdings Corp. (the "Lender"), an entity controlled by the Company's largest indirect beneficial shareholder Avonlea-Drewry Holdings Inc. ("ADH"), and which is a party to the Company's previously announced letter of intent ("LOI") in respect of a proposed business acquisition, recapitalization and debt restructur
CNW GroupPATHWAY HEALTH CORP. SIGNS NON-BINDING LETTER OF INTENT FOR PROPOSED BUSINESS ACQUISITION, RECAPITALIZATION AND DEBT RESTRUCTURING
Pathway Health Corp. (TSXV: PHC) (Frankfurt: KL1) ("Pathway" or the "Corporation") is pleased to announce it has entered into a non-binding letter of intent dated December 16, 2022 ("LOI") whereby it is proposed that Pathway will acquire all of the issued and outstanding common shares of each of HEAL Global Holdings Corp. ("HEAL") and The Newly Institute Inc. ("The Newly") from their respective shareholders, in exchange for common shares in the capital of Pathway ("Shares") currently intended to
CNW GroupPathway Health Corp. Reports Third Quarter 2022 Financial Results
Pathway Health Corp. (TSXV: PHC) (Frankfurt: KL1) (formerly Colson Capital Corp.) ("Pathway" or the "Company"), a Canadian leader in chronic pain solutions and management services, is pleased to report its financial results for the three and nine-month period ended September 30, 2022. Unless otherwise noted, all amounts are in Canadian dollars and are prepared in accordance with International Financial Reporting Standards ("IFRS").
CNW GroupPATHWAY HEALTH CORP. ANNOUNCES CHANGE OF AUDITOR
Pathway Health Corp. (TSXV: PHC) (Frankfurt: KL1) ("Pathway" or the "Corporation") is pleased to announce the appointment of MNP LLP as its new auditor effective as of November 10, 2022.
CNW GroupPathway Health Corp. Announces Collaboration Agreement with Sunshine Drugs Family of Pharmacies
Pathway Health Corp. (TSXV: PHC) (Frankfurt: KL1) (formerly Colson Capital Corp.) ("Pathway" or the "Company"), an integrated healthcare company that provides products and services to patients suffering from chronic pain and related conditions, is pleased to announce that it has signed a Collaboration Agreement (the "Agreement") with Sunshine Drugs, a family of 15 community based pharmacies located primarily in Southwest Ontario. The agreement details the implementation of Pathway's Medical Cann
CNW GroupPathway Health Corp. Announces Acquisition of Certain Assets of IRP Health Ltd.
Pathway Health Corp. (TSXV: PHC) (Frankfurt: KL1) (formerly Colson Capital Corp.) ("Pathway" or the "Company"), an integrated healthcare company that provides products and services to patients suffering from chronic pain and related conditions, is pleased to announce that it has entered into an arm's length asset purchase agreement to acquire all or substantially all the operating assets (the "Transaction") of IRP Health Ltd. ("IRP") a wholly owned subsidiary of Wellbeing Digital Sciences Inc. (
CNW GroupPathway Health Corp. Issues Stock Options
Pathway Health Corp. (TSXV: PHC) (Frankfurt: KL1) (formerly Colson Capital Corp.) ("Pathway" or the "Company"), an integrated healthcare company that provides products and services to patients suffering from chronic pain and related conditions, announces the grant of 3,505,593 stock options to directors, officers, employees and consultants on September 28, 2022. Of the stock options being issued, 2,074,025 options are being granted to directors and senior officers, 1,131,568 options to employees
CNW GroupPathway Health Corp. Reports Second Quarter 2022 Financial Results
Pathway Health Corp. (TSXV: PHC) (Frankfurt: KL1) (formerly Colson Capital Corp.) ("Pathway" or the "Company"), a Canadian leader in chronic pain solutions and management services, is pleased to report its financial results for the three and six-month period ended June 30, 2022. Unless otherwise noted, all amounts are in Canadian dollars and are prepared in accordance with International Financial Reporting Standards ("IFRS").